These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 8876979)

  • 1. Studies on receptor binding site of insulin: the hydrophobic B12Val can be substituted by hydrophilic thr.
    Wang QQ; Feng YM; Zhang YS
    Biochem Mol Biol Int; 1996 Aug; 39(6):1245-54. PubMed ID: 8876979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutational analysis of the three conserved valine residues of insulin and a proposal of "isosteric residue".
    Guo ZY; Tang YH; Zhang Z; Feng YM
    IUBMB Life; 2001 Dec; 52(6):309-14. PubMed ID: 11895080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydrophilic Thr can replace the hydrophobic and absolutely conservative A3Val in insulin.
    Chen H; Feng YM
    Biochim Biophys Acta; 1998 Dec; 1429(1):69-73. PubMed ID: 9920385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isosteric replacement of A3 Val of porcine insulin by allo-Thr.
    Li M; Cui D; Zhang Y
    IUBMB Life; 2002 Jan; 53(1):57-60. PubMed ID: 12018409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of deletion and shift of the A20-B19 disulfide bond on the structure, activity, and refolding of proinsulin.
    Wang ZH; Liu Y; Ji JG; Tang JG
    J Biochem; 2004 Jan; 135(1):25-31. PubMed ID: 14999006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutational analysis of invariant valine B12 in insulin: implications for receptor binding.
    Nakagawa SH; Tager HS; Steiner DF
    Biochemistry; 2000 Dec; 39(51):15826-35. PubMed ID: 11123908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutagenesis of the three conserved valine residues: consequence on the foldability of insulin.
    Guo ZY; Wang S; Tang YH; Feng YM
    Biochim Biophys Acta; 2004 Jun; 1699(1-2):103-9. PubMed ID: 15158717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Receptor binding and biologic activity of biosynthetic human insulin and mini-proinsulin produced by recombinant gene technology.
    Kobayashi M; Sasaoka T; Sugibayashi M; Iwanishi M; Shigeta Y
    Diabetes Res Clin Pract; 1989 Jun; 7(1):25-8. PubMed ID: 2666066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of cysteine to serine substitutions in the two inter-chain disulfide bonds of insulin.
    Guo ZY; Feng YM
    Biol Chem; 2001 Mar; 382(3):443-8. PubMed ID: 11347892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Analogs of human proinsulin. Obtaining a deletion at the site of the proinsulin gene encoding the region of receptor binding].
    Gur'ev SO; Tialina IuIu; Trakhanova MN; Iarotskiĭ SV
    Antibiot Khimioter; 1994 Apr; 39(4):3-7. PubMed ID: 7826171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contribution of the conserved A16Leu to insulin foldability.
    Zhang ZJ; Wu L; Qiao ZS; Qiao MQ; Feng YM; Guo ZY
    Protein J; 2008 Apr; 27(3):192-6. PubMed ID: 18071885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Yeast secretory expression of insulin precursors.
    Kjeldsen T
    Appl Microbiol Biotechnol; 2000 Sep; 54(3):277-86. PubMed ID: 11030562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intra-A chain disulfide bond (A6-11) of insulin is essential for displaying its activity.
    Dai Y; Tang JG
    Biochem Mol Biol Int; 1994 Aug; 33(6):1049-53. PubMed ID: 7804129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding of proinsulin and proinsulin conversion intermediates to human placental insulin-like growth factor I receptors.
    Gruppuso PA; Frank BH; Schwartz R
    J Clin Endocrinol Metab; 1988 Jul; 67(1):194-7. PubMed ID: 2967852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural determinants of ligand recognition by type I insulin-like growth factor receptors: use of semisynthetic insulin analog probes.
    Cara JF; Nakagawa SH; Tager HS
    Endocrinology; 1988 Jun; 122(6):2881-7. PubMed ID: 2967179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Processing of mutated proinsulin with tetrabasic cleavage sites to mature insulin reflects the expression of furin in nonendocrine cell lines.
    Yanagita M; Hoshino H; Nakayama K; Takeuchi T
    Endocrinology; 1993 Aug; 133(2):639-44. PubMed ID: 8344203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Receptor binding properties of human insulin (recombinant DNA) and human proinsulin and their interaction at the receptor site.
    Prager R; Schernthaner G
    Diabetes Care; 1982; 5 Suppl 2():104-6. PubMed ID: 6765518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sequence requirements for proinsulin processing at the B-chain/C-peptide junction.
    Kaufmann JE; Irminger JC; Halban PA
    Biochem J; 1995 Sep; 310 ( Pt 3)(Pt 3):869-74. PubMed ID: 7575420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro evolution of amphioxus insulin-like peptide to mammalian insulin.
    Guo ZY; Shen L; Gu W; Wu AZ; Ma JG; Feng YM
    Biochemistry; 2002 Aug; 41(34):10603-7. PubMed ID: 12186544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hydroxyl group of insulin A19Tyr is essential for receptor binding: studies on (A19Phe)insulin.
    Du X; Tang JG
    Biochem Mol Biol Int; 1998 Jun; 45(2):255-60. PubMed ID: 9678246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.